"A high-tech double-barrel nanopipette, developed by University of Leeds scientists, and applied to the global medical challenge of cancer, has—for the first time—enabled researchers to see how individual living cancer cells react to treatment and change over time—providing vital understanding that could help doctors develop more effective cancer medication. Their findings are published in the journal Science Advances. The tool has two nanoscopic needles, meaning it can simultaneously inject and extract a sample from the same cell, expanding its potential uses. And the platform's high level of semi-automation has sped up the process dramatically, enabling scientists to extract data from many more individual cells, with far greater accuracy and efficiency than previously possible, the study shows." #cancer #oncology
William (Bill) Kemp’s Post
More Relevant Posts
-
🔍 In case you missed it, researchers have made an exciting breakthrough in cancer treatment with the development of a nanosurgical tool. This innovative approach allows for precise targeting and biopsy of cancer cells that survive chemotherapy, opening new doors for understanding and treating the most stubborn forms of the disease. We are always excited to share pioneering developments that could transform patient care. This represents the kind of innovative work we admire and support in the medical community. 🌐 Discover more about how this technology is paving the way for new cancer treatments: Read about the nanosurgical tool: https://lnkd.in/en3gna8u #CancerResearch #InnovativeMedicine #FloMedical
Nanosurgical tool could be key to cancer breakthrough
sciencedaily.com
-
Over the last two years, the Cancer Bioengineering Initiative (CBI) has become a three-grant center dedicated to integrating engineering into cancer therapies – but its roots didn’t actually stem from cancer research. Read about how it began with an idea and a seed grant: https://lnkd.in/e2eSVnvi #cancerbioengineering #cancerdrugs #cancertrials #modeling #cellmigration #drugdevelopment #biomedicalengineering #bioengineering
From Seed to Center
med.umn.edu
-
What is the role of the TME in lung cancer evolution? - Charles Swanton American Association for Cancer Research The Francis Crick Institute Cancer Research UK (CRUK) https://lnkd.in/dXsdHmrA #Biomarkers #Cancer #CancerResearch #CD8 #LungCancer #Metastasis #MyeloidCells #BiomedicalResearch #NSCLC #OncoDaily #Oncology
Charles Swanton: What is the role of the TME in lung cancer evolution? - OncoDaily
oncodaily.com
-
Groundbreaking #AI Study to Personalize Breast Cancer Therapy Incredible news from The Institute of Cancer Research: a new AI-VISION study is set to revolutionize the way we approach triple-negative breast cancer treatment. By combining AI with genomic data, researchers aim to tailor treatments for better patient outcomes. #BreastCancer #MedicalAI #PersonalizedMedicine #HealthcareInnovation https://vist.ly/33eag
New AI collaboration could advance precision therapy in breast cancer
icr.ac.uk
-
MicroQuin is pushing the boundaries of cancer research by taking it to space. In collaboration with the International Space Station, MicroQuin is studying how 3D breast and prostate cancer cultures behave in microgravity. This unique environment offers new insights into tumour growth and signalling pathways. Read the full article here: https://hubs.la/Q02Vg6tc0
MicroQuin’s Space-Based Research Uncovers New Pathways in Cancer Treatment
oxfordglobal.com
-
Gen Ai & Automation Expert | Tech Advisor | Driving Business Mobility & IoT , Cloud Innovation, and Cybersecurity | Empowering Digital Transformation & Unified Communications, Network Connectivity, Sales, Coaching
Groundbreaking #AI Study to Personalize Breast Cancer Therapy Incredible news from The Institute of Cancer Research: a new AI-VISION study is set to revolutionize the way we approach triple-negative breast cancer treatment. By combining AI with genomic data, researchers aim to tailor treatments for better patient outcomes. #BreastCancer #MedicalAI #PersonalizedMedicine #HealthcareInnovation https://vist.ly/33eae
New AI collaboration could advance precision therapy in breast cancer
icr.ac.uk
-
Groundbreaking #AI Study to Personalize Breast Cancer Therapy Incredible news from The Institute of Cancer Research: a new AI-VISION study is set to revolutionize the way we approach triple-negative breast cancer treatment. By combining AI with genomic data, researchers aim to tailor treatments for better patient outcomes. #BreastCancer #MedicalAI #PersonalizedMedicine #HealthcareInnovation https://vist.ly/33eab
New AI collaboration could advance precision therapy in breast cancer
icr.ac.uk
-
Exciting breakthrough in cancer detection! Researchers have enhanced blood tests, making it easier to detect circulating tumor DNA. This advancement could lead to earlier cancer diagnosis and more informed treatment decisions. Read more about this ground-breaking on MIT News: https://lnkd.in/gynUEwcJ #blood #bloodtest #healthcaretechnology #medicalinnovation #cancerdetection #biomedicalengineering
Researchers improve blood tests’ ability to detect and monitor cancer
news.mit.edu
-
"A computer program based on data from nearly a half-million tissue images and powered by artificial intelligence can accurately diagnose cases of adenocarcinoma, the most common form of lung cancer, a new study shows. Researchers at NYU Langone Health's Perlmutter Cancer Center and the University of Glasgow developed and tested the program. They say that because it incorporates structural features of tumors from 452 adenocarcinoma patients, who are among the more than 11,000 patients in the United States National Cancer Institute's Cancer Genome Atlas, the program offers an unbiased, detailed, and reliable second opinion for patients and oncologists about the presence of the cancer and the likelihood and timing of its return (prognosis)." #cancer #oncology #lungcancer #ai
'Self-taught' AI tool helps to diagnose and predict severity of common lung cancer
medicalxpress.com
-
MicroQuin is pushing the boundaries of cancer research by taking it to space. In collaboration with the International Space Station, MicroQuin is studying how 3D breast and prostate cancer cultures behave in microgravity. This unique environment offers new insights into tumour growth and signalling pathways. Read the full article here: https://hubs.la/Q02VgxbD0
MicroQuin’s Space-Based Research Uncovers New Pathways in Cancer Treatment
oxfordglobal.com
